Drug application
ALHEMO (CONCIZUMAB)
Drugs@FDA BLA 761428 · NOVO NORDISK INC
Key facts
| Drug name | ALHEMO |
|---|---|
| Active ingredients | CONCIZUMAB |
| Application type | BLA |
| Application number | 761428 |
| Company | NOVO NORDISK INC |
| Dosage forms | SOLUTION, INJECTION |
| Strength | 60MG/1.5ML (40MG/ML) |
| Marketing status | Prescription |
| Reference listed drug | No |
| Latest submission class | Type 9 - New indication submitted as distinct BLA, consolidated |
| Latest submission status date | Jul 31, 2025 |
At a glance
- 1–9 Submissions
- 1–9 Label versions
- 1–9 Products
- None Therapeutic equivalents
- Yes FDA letters on file
- No FDA reviews on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: